T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

December 31, 2004

Conditions
HIV Infections
Interventions
DRUG

Enfuvirtide

Trial Locations (7)

10021

New York Hosp - Cornell / Program for Children with AIDS, New York

10029

Mount Sinai Hosp, New York

10457

Bronx Lebanon Hosp Ctr, The Bronx

10461

Bronx Municipal Hosp Ctr/Jacobi Med Ctr, The Bronx

23507

Children's Hosp of the King's Daughters, Norfolk

32610

Univ of Florida Gainesville, Gainesville

90027

Children's Hosp Los Angeles, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Trimeris

INDUSTRY

lead

Hoffmann-La Roche

INDUSTRY

NCT00022763 - T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents | Biotech Hunter | Biotech Hunter